Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Reactogenicity of 13-valent Pneumococcal Conjugate Vaccine Among Infants, Toddlers and Children in Bobo-Dioulasso, Burkina Faso: a Phase 4 Randomized Trial

NCT01577771 is registered in ClinicalTrials.gov with Agence de Médecine Préventive, France as lead sponsor.

NCT NCT01577771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01577771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Reactogenicity of 13-valent Pneumococcal Conjugate Vaccine Among Infants, Toddlers and Children in Bobo-Dioulasso, Burkina Faso: a Phase 4 Randomized Trial
Lead sponsor
Agence de Médecine Préventive, France
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2013
Completion date
May 31, 2014
Enrollment
663 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal infections